Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial | Synapse
April 3, 2017Open Access
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
Key Points
Key points are not available for this paper at this time.
Abstract
UK Medical Research Council and National Institute for Health Research.